EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Abstract 6367: Apolipoprotein B-LDL Cholesterol Discordance and Residual Cardiovascular Risk: A Systematic Review and Meta-Analysis

JESUS ABRAHAM SIMON CAMPOS, PEDRO CAMPOS-CORZO, felipe de jesus pineda cardenas, JORGE ANGELARES CRUZ, OSCAR EDUARDO KANTUN KOH, Gerardo Viana, EMMANUEL LIZAMA, ENRIQUE CASTANO- DE LA SERNA

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.6367 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von JESUS ABRAHAM SIMON CAMPOS und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients achieving guideline-directed LDL-C targets continue to experience cardiovascular events, suggesting that LDL-C may incompletely reflect atherogenic particle burden, more directly indexed by apolipoprotein B (ApoB). In metabolically complex patients (obesity, insulin resistance, metabolic syndrome, diabetes, or hypertriglyceridemia), LDL particles tend to be cholesterol-depleted but numerically abundant, creating ApoB–LDL-C discordance. Hypothesis: ApoB-predominant discordance, with elevated ApoB despite lower LDL-C, is associated with increased cardiovascular risk and greater subclinical atherosclerotic burden.

Methods

We conducted a systematic review and meta-analysis (PROSPERO CRD420261401224; PRISMA/MOOSE) of PubMed, Embase, Web of Science, Scopus, and Cochrane through May 10, 2026. We restricted primary analyses to studies with homogeneous median-split or phenotype-based discordance definitions (3 clinical, 3 subclinical) and expanded sensitivity analyses to residual- and percentile-based definitions. We pooled adjusted effects using random-effects meta-analysis with REML estimation, and assessed risk of bias (Newcastle-Ottawa Scale) and certainty (GRADE).

Results

Eleven observational studies met inclusion criteria. The primary clinical meta-analysis (3 studies; 49,739 participants) showed increased cardiovascular risk with ApoB-predominant discordance (pooled effect, 1.45; 95% CI, 1.24–1.70; I 2 =0%; P

Zitieren

APA

CAMPOS, J. A. S., CAMPOS-CORZO, P., cardenas, F. D. J. P., CRUZ, J. A., KOH, O. E. K., Viana, G., LIZAMA, E., & SERNA, E. C. D. L. (2026). Abstract 6367: Apolipoprotein B-LDL Cholesterol Discordance and Residual Cardiovascular Risk: A Systematic Review and Meta-Analysis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.6367

Vancouver

CAMPOS JAS, CAMPOS-CORZO P, cardenas FDJP, CRUZ JA, KOH OEK, Viana G, et al. Abstract 6367: Apolipoprotein B-LDL Cholesterol Discordance and Residual Cardiovascular Risk: A Systematic Review and Meta-Analysis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.6367

BibTeX
@article{CAMPOS2026,
  author = {CAMPOS, JESUS ABRAHAM SIMON and CAMPOS-CORZO, PEDRO and cardenas, felipe de jesus pineda and CRUZ, JORGE ANGELARES and KOH, OSCAR EDUARDO KANTUN and Viana, Gerardo and LIZAMA, EMMANUEL and SERNA, ENRIQUE CASTANO- DE LA},
  title = {Abstract 6367: Apolipoprotein B-LDL Cholesterol Discordance and Residual Cardiovascular Risk: A Systematic Review and Meta-Analysis},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.6367}
}
Kostenlos starten →